![Martin Phillips](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Martin Phillips
Amministratore Delegato presso
Opsidio LLC
Profilo
Martin Phillips currently works at Opsidio LLC, as Chief Executive Officer & Director from 2017.
Dr. Phillips also formerly worked at Aventis Behring, as Senior Medical Director, Context Therapeutics LLC, as Director, Morphotek, Inc., as Chief Medical Officer & SVP-Clinical Development, Millendo Therapeutics US, Inc., as Chief Medical Officer, The University of Texas at Austin, as Associate Professor-Medicine, and Baylor College of Medicine, as Assistant Professor-Medicine.
Dr. Phillips received his doctorate degree from Wayne State University (Michigan) and undergraduate degree from the University of Michigan.
Posizioni attive di Martin Phillips
| Società | Posizione | Inizio |
|---|---|---|
Opsidio LLC
 Opsidio LLC Pharmaceuticals: MajorHealth Technology Engages in developing monoclonal antibodies to treat fibrotic and remodeling diseases | Amministratore Delegato | 03/10/2017 |
Precedenti posizioni note di Martin Phillips
| Società | Posizione | Fine |
|---|---|---|
Aventis Behring
 Aventis Behring Pharmaceuticals: MajorHealth Technology Develops pharmaceutical and agricultural products | Direttore Tecnico/Scientifico/R&S | - |
Context Therapeutics LLC
 Context Therapeutics LLC Pharmaceuticals: MajorHealth Technology Manufactures hormone-responsive cancer drugs | Direttore/Membro del Consiglio | - |
Millendo Therapeutics US, Inc.
 Millendo Therapeutics US, Inc. Pharmaceuticals: MajorHealth Technology Operates as a holding company which develops a novel treatment for adrenal cancer | Direttore Tecnico/Scientifico/R&S | - |
The University of Texas at Austin
 The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Baylor College of Medicine
 Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Formazione di Martin Phillips
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
11
Relazioni di 1° grado
9
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 9 |
|---|---|
Morphotek, Inc.
 Morphotek, Inc. BiotechnologyHealth Technology Develops oncology therapies | Health Technology |
Millendo Therapeutics US, Inc.
Millendo Therapeutics US, Inc. Pharmaceuticals: MajorHealth Technology Operates as a holding company which develops a novel treatment for adrenal cancer | Health Technology |
Wayne State University (Michigan)
 Wayne State University (Michigan) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aventis Behring
Aventis Behring Pharmaceuticals: MajorHealth Technology Develops pharmaceutical and agricultural products | Health Technology |
The University of Texas at Austin
The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Baylor College of Medicine
Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Opsidio LLC
Opsidio LLC Pharmaceuticals: MajorHealth Technology Engages in developing monoclonal antibodies to treat fibrotic and remodeling diseases | Health Technology |
Context Therapeutics LLC
Context Therapeutics LLC Pharmaceuticals: MajorHealth Technology Manufactures hormone-responsive cancer drugs | Health Technology |
